NEURALSTEM INC. news, videos and press releases
For more news please use our advanced search feature.
NEURALSTEM INC. - More news...
NEURALSTEM INC. - More news...
-
Neuralstem, Inc. - CUR Stock Chart Technical Analysis for 10-30-2019
- Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases
- Neuralstem Becomes Seneca Biopharma
- Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)
- Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
- Neuralstem Reports Second Quarter 2019 Fiscal Results
- Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued Listing
- Neuralstem Closes $7.5 Million Underwritten Public Offering
- Neuralstem Announces Pricing of $7.5 Million Underwritten Public Offering
- Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
- Neuralstem Announces a 1-for-20 Reverse Stock Split
- Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
- Neuralstem Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem Cells
- Neuralstem Reports First Quarter 2019 Fiscal Results
- Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors
- Neuralstem to Expand Pipeline as Part of Aggressive Growth Effort
-
Neuralstem, Inc. - CUR Stock Chart Technical Analysis for 10-25-18
-
Neuralstem, Inc. - CUR Stock Chart Technical Analysis for 07-23-18
-
Neuralstem, Inc. - CUR Stock Chart Technical Analysis for 04-10-18
-
Neuralstem Inc - CUR Stock Chart Technical Analysis for 12-05-17
- Neuralstem Announces a 1-for-13 Reverse Stock Split
- Neuralstem Announces the Closing of $20 Million Strategic Investment from Tianjin Pharmaceutical Group International Holdings Co., LTD.
- Neuralstem Reports Third Quarter 2016 Results
- Neuralstem Announces Presentations at Upcoming Scientific Conferences
